Roivant Sciences Ltd.
SEC CIK 1635088 · ROIV · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Manchester Keith S | Director | filed 2021 - 2026 |
| QVT Financial LP | Director | filed 2021 - 2026 |
| Gold Daniel Allen | Director | filed 2021 - 2026 |
| Sukhatme Mayukh | Director · See Remarks | filed 2021 - 2026 |
| Momtazee James C | Director | filed 2021 - 2026 |
| Oren Ilan | Director | filed 2021 - 2026 |
| Epperly Melissa B, | Director | filed 2022 - 2026 |
| Gline Matthew | Director · CEO | filed 2021 - 2026 |
| Fitzgerald Meghan | Director | filed 2023 - 2026 |
| Ramaswamy Vivek | Director | filed 2021 - 2025 |
| Nomura Hiroshi | Director | filed 2022 - 2022 |
| Lo Andrew | Director | filed 2021 - 2022 |
| Machado Patrick | Director | filed 2021 - 2021 |
| Tada Masayo | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Venker Eric | President & Immunovant CEO | filed 2021 - 2026 |
| Pulik Richard | CHIEF FINANCIAL OFFICER | filed 2021 - 2026 |
| Humes Jennifer | Chief Accounting Officer | filed 2025 - 2026 |
| Torti Frank | President and Vant Chair | filed 2025 - 2026 |
| Kumar Rakhi | Chief Accounting Officer | filed 2021 - 2025 |
| Zimmer Benjamin | President, Roivant Health | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.